The Company offers a broad range of solutions which includes clinical development strategies, therapeutic expertise, predictive and prescriptive analytics, and patient retention services. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.Harvard Medical School Health Care Policy Advisory CouncilIQVIA Holdings Inc. focuses on technology solutions and contract research services. ... and promotions / progressions are a percent increase in your salary so this could affect your salary for your entire career at IQVIA) - The staffing model is that you are expected to be on multiple projects at all time. Ari Bousbib is Chairman/President/CEO at Iqvia Holdings Inc. See Ari Bousbib's compensation, career history, education, & memberships. IQVIA continues to boost its growth numbers through acquisitions, spending $923 million on a variety of smaller deals in 2017. Of this total $515,000 was received as a salary, $550,000 was received as a bonus, $602,661 was received in stock options, $659,961 was awarded as stock and $41,537 came from other types of compensation. Ari Bousbib has been the CEO of IQVIA Holdings Inc. since 2016.First, this article will compare CEO compensation with compensation at other large companies.
Over the past four years, Bruehlman has served as a senior advisor to Iqvia CEO Ari Bousbib. Ari Bousbib. Check out our latest analysis for IQVIA Holdings . But his base salary… He begins the new job on Aug. 1.Mike McDonnell is leaving IQVIA’s CFO post to become Chief Financial Officer of Biogen Inc.“Ron was previously the Chief Financial Officer of IMS Health from 2011 until the merger of IMS Health and Quintiles in 2016.
Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Bousbib,” IQVIA announced.“During this time, Ron regularly participated in key management meetings, operational reviews, preparation of quarterly earnings reports, and board meetings, providing on-going guidance and support to Mike and the senior finance team. Mr. Bousbib owns over 46,080 units of IQVIA stock worth over $102,904,164 and over the last 17 years he sold IQV stock worth over $178,255,145. According to our data, IQVIA Holdings Inc. has a market capitalization of US$29b, and paid its CEO total annual compensation worth US$16m over … The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.05 per share.“Against the background of the ongoing COVID-19 situation, we delivered second quarter results that exceeded our expectations,” said Ari Bousbib, chairman and CEO of IQVIA.“As we had assumed, the R&DS business saw a gradual increase in the accessibility of clinical research sites, exiting the quarter at 40 percent accessibility and currently at 53 percent, resulting in an improvement in the number of weekly onsite visits from the start of the quarter. Ari Bousbib is a businessperson who has been the head of 9 different companies. I am proud of how the IQVIA team is executing in this environment – supporting our improved outlook for the year.”The clinical testing company posted revenue of $2.52 billion in the period, also exceeding Street forecasts. How Does Ari Bousbib’s Compensation Compare With Similar Sized Companies? As Executive Vice President, General Counsel and Secretary at IQVIA HOLDINGS INC., Eric M. Sherbet made $2,369,159 in total compensation.
Close. Seven analysts surveyed by Zacks expected $2.41 billion.IQVIA expects full-year earnings in the range of $6.10 to $6.30 per share, with revenue expected to be $11 billion.IQVIA shares have increased almost 2% since the beginning of the year. For McDonnell, the Biogen move means a major salary uptick.
Mr. Bousbib owns over 164,877 units of IQVIA stock worth over $90,515,499 and over the last 17 years he sold IQV stock worth over $170,882,345. 1,230 Ratings. "Against the background of the ongoing COVID-19 situation, we delivered second quarter results that exceeded our expectations," says Ari Bousbib, chairman and CEO of IQVIA. Since the merger, Ron has continued to play an active role on the executive leadership team at IQVIA, serving as a senior advisor to Ari Bousbib, Chairman and CEO of IQVIA.